[1]
S. A. Serik and T. H. Ovrakh, “Association between cystatin C and major adverse cardiac events in patients with ischemic heart disease and type 2 diabetes mellitus after acute coronary syndrome”, Zaporozhye Medical Journal, no. 3, May 2019.